The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Sumit K. Subudhi, MD, PhD, on Managing Apalutamide Toxicities in Prostate Cancer

Posted: Wednesday, March 6, 2019

How do you prevent or reduce osteopenia and osteoporosis in patients who receive apalutamide?



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.